{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:48:59Z","timestamp":1789904939607,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13256-015-0630-8","type":"journal-article","created":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T14:37:18Z","timestamp":1438007838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Alexander R.","family":"Ende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Landis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"630_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(14)61036-9","volume":"384","author":"E Lawitz","year":"2014","unstructured":"Lawitz E, Sulkowski MS, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet. 2014;384:1756\u201365.","journal-title":"Lancet."},{"key":"630_CR2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.23461","volume":"51","author":"EJ Bini","year":"2010","unstructured":"Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial\/ethnic differences, and viral interactions. Hepatology. 2010;51:759\u201366.","journal-title":"Hepatology."},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1440-1746.2008.05384.x","volume":"23","author":"CJ Chu","year":"2008","unstructured":"Chu CJ, Lee SD. Hepatitis B virus\/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol. 2008;23:512\u201320.","journal-title":"J Gastroenterol Hepatol."},{"key":"630_CR4","first-page":"122","volume":"42","author":"S Saravanan","year":"2009","unstructured":"Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, et al. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect. 2009;42:122\u20138.","journal-title":"J Microbiol Immunol Infect."},{"key":"630_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.26400","volume":"58","author":"GL Tyson","year":"2013","unstructured":"Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013;58:538\u201345.","journal-title":"Hepatology."},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(06)69374-4","volume":"368","author":"J Amin","year":"2006","unstructured":"Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938\u201345.","journal-title":"Lancet."},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-4-13","volume":"4","author":"SD Crockett","year":"2005","unstructured":"Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob. 2005;4:13.","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"630_CR8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/hep.26266","volume":"57","author":"ML Yu","year":"2013","unstructured":"Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, et al. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology. 2013;57:2135\u201342.","journal-title":"Hepatology."},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u20132.","journal-title":"Hepatology."},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s005350050359","volume":"35","author":"E1 Galban-Garc\u00eda","year":"2000","unstructured":"Galban-Garc\u00eda E1, Vega-Sanchez H, Gra-Oramas B, Jorge-Ria\u00f1o JL, Soneiras-Perez M, Haedo-Castro D, et al. Efficacy of ribavirin in patients with chronic hepatitis B. J Gastroenterol. 2000;35:347\u201352.","journal-title":"J Gastroenterol"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1572-0241.2001.03633.x","volume":"96","author":"F Siddiqui","year":"2001","unstructured":"Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. Am J Gastroenterol. 2001;96:858\u201363.","journal-title":"Am J Gastroenterol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-015-0630-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:01:17Z","timestamp":1748545277000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-015-0630-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/s13256-015-0630-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"article-number":"164"}}